VERADERMICS Stock Price, News & Analysis
Company Description
VERADERMICS (NYSE: MANE) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.4B, ranking #2,027 among all listed U.S. companies by market cap.
MANE stock has gained 73.6% over the past year. Shares last traded at $65.53.
This page provides a comprehensive overview of MANE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
VERADERMICS (MANE) stock last traded at $65.53, down 5.26% from the previous close. Over the past 12 months, the stock has gained 73.6%. At a market capitalization of $2.4B, MANE is classified as a mid-cap stock with approximately 35.1M shares outstanding.
Latest News
VERADERMICS has 6 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 3 with negative movement. Key topics include IPO, clinical trial, offering. View all MANE news →
SEC Filings
VERADERMICS has filed 5 recent SEC filings, including 3 Form SCHEDULE 13D, 1 Form 4/A, 1 Form SCHEDULE 13G. The most recent filing was submitted on February 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all MANE SEC filings →
Insider Radar
Insider buying activity at VERADERMICS over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Phase 3 '304' topline data
VERADERMICS has 1 upcoming scheduled event. The next event, "Phase 3 '304' topline data", is scheduled for July 1, 2026 (in 94 days). Investors can track these dates to stay informed about potential catalysts that may affect the MANE stock price.
Short Interest History
Days to Cover History
MANE Company Profile & Sector Positioning
VERADERMICS (MANE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NYSE.